VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N902. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,162 | +98.4% | 42,600 | +419.5% | 0.00% | 0.0% |
| Q2 2023 | $201,146 | -82.9% | 8,200 | -83.8% | 0.00% | -75.0% |
| Q1 2023 | $1,175,135 | +1397.7% | 50,500 | +1529.0% | 0.00% | – |
| Q4 2022 | $78,461 | -72.5% | 3,100 | -79.1% | 0.00% | -100.0% |
| Q3 2022 | $285,000 | -72.8% | 14,800 | -64.1% | 0.00% | -50.0% |
| Q2 2022 | $1,049,000 | -63.3% | 41,200 | -62.9% | 0.00% | -33.3% |
| Q1 2022 | $2,855,000 | -51.9% | 111,000 | -21.8% | 0.00% | -40.0% |
| Q4 2021 | $5,941,000 | +35.6% | 141,900 | +40.9% | 0.01% | 0.0% |
| Q3 2021 | $4,382,000 | +145.2% | 100,700 | +166.4% | 0.01% | +150.0% |
| Q2 2021 | $1,787,000 | -54.0% | 37,800 | -50.1% | 0.00% | -66.7% |
| Q1 2021 | $3,881,000 | +484.5% | 75,700 | +205.2% | 0.01% | +500.0% |
| Q4 2020 | $664,000 | +32.5% | 24,800 | +69.9% | 0.00% | -50.0% |
| Q3 2020 | $501,000 | -51.9% | 14,600 | -42.5% | 0.00% | -60.0% |
| Q2 2020 | $1,041,000 | +398.1% | 25,400 | +316.4% | 0.01% | +150.0% |
| Q1 2020 | $209,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 100,700 | $4,382,000 | 0.01% |
| SIMPLEX TRADING, LLC | 3,724 | $162,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |